Gubra AS receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gubra AS (GUBRA)
Gubra AS stock price live, this page displays CSE GUBRA stock exchange data. View the GUBRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gubra AS real time stock price chart below.
What Is the Gubra AS Stock Price Today?
The Gubra AS stock price today is 375.20.
What Is the Stock Symbol for Gubra AS?
The stock symbol for Gubra AS is ""GUBRA.""
What Stock Exchange Does Gubra AS Trade On?
Gubra AS is listed and trades on the Copenhagen stock exchange.
Is Gubra AS a Good Stock to Buy?
Determining whether Gubra AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GUBRA quote. (ISIN: DK0062266474)
What Is the Gubra AS Stock Price Today?
The Gubra AS stock price today is 375.20.
What Is the Stock Symbol for Gubra AS?
The stock symbol for Gubra AS is ""GUBRA.""
What Stock Exchange Does Gubra AS Trade On?
Gubra AS is listed and trades on the Copenhagen stock exchange.
Is Gubra AS a Good Stock to Buy?
Determining whether Gubra AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GUBRA quote. (ISIN: DK0062266474)
Copenhagen
Currency in DKK
375.20
-8.80(-2.29%)
Closed·
Fair Value
An estimate of a Gubra AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
373.00
384.00
52 wk Range
318.40
748.00
GUBRA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
1/2
Fair Value
An estimate of a Gubra AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
373.00384.00
52 wk Range
318.40748.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.31%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GUBRA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Gubra AS's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
502.50
Upside
+33.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Gubra AS receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Gubra AS receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Gubra AS Company Profile
Gubra A/S, a biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally. The company operates through three segments: Pre-Clinical Contract Research (CRO), Discovery & Partnerships, and Gubra Green. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, pharmacokinetics, and 2D and 3D histology with artificial intelligence pathology. The company has partnership and collaboration with Boehringer Ingelheim for the treatment of obesity; Hemab ApS to treat bleeding disorders; and Amylyx Pharmaceuticals, Inc. to develop a novel long-acting GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseases. Gubra A/S was incorporated in 2008 and is based in Horsholm, Denmark.
Gubra AS Earnings Call Summary for Q1/2025
- Gubra reports Q1 2025 results: $350M upfront from AbbVie deal, potential $1.875B in milestones; stock rises 2.6%
- GUPAMI program shows promising weight loss results; UCN2 obesity program first-in-human study planned for early 2026
- CRO revenue slightly down YoY, but company maintains 20% growth guidance for full-year 2025
- Management evaluating M&A opportunities; analysts project strong sales growth and EPS of $18.04 for FY2025
- Slight decline in CRO revenue and longer US decision times pose challenges; focus shifts to quality of weight loss in treatments
Last Updated: 09/05/2025, 09:30
Read Full TranscriptCompare GUBRA to Peers and Sector
Metrics to compare | GUBRA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGUBRAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 3.5x | −2.7x | −0.6x | |
PEG Ratio | 0.00 | 0.03 | 0.00 | |
Price/Book | 5.0x | 1.2x | 2.6x | |
Price / LTM Sales | 2.3x | 2.2x | 3.3x | |
Upside (Analyst Target) | 33.9% | 31.9% | 39.1% | |
Fair Value Upside | Unlock | 3.3% | 5.4% | Unlock |
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 502.50
(+33.93% Upside)
Earnings
Latest Release
Aug 21, 2025
EPS / Forecast
107.10 / --
Revenue / Forecast
2.44B / --
People Also Watch
FAQ
What Stock Exchange Does Gubra AS Trade On?
Gubra AS is listed and trades on the Copenhagen Stock Exchange stock exchange.
What Is the Stock Symbol for Gubra AS?
The stock symbol for Gubra AS is "GUBRA."
What Is the Gubra AS Market Cap?
As of today, Gubra AS market cap is 5.76B.
What Is Gubra AS's Earnings Per Share (TTM)?
The Gubra AS EPS (TTM) is 108.71.
When Is the Next Gubra AS Earnings Date?
Gubra AS will release its next earnings report on 06 Nov 2025.
From a Technical Analysis Perspective, Is GUBRA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Gubra AS Stock Split?
Gubra AS has split 0 times.
How Many Employees Does Gubra AS Have?
Gubra AS has 275 employees.
What is the current trading status of Gubra AS (GUBRA)?
As of 29 Aug 2025, Gubra AS (GUBRA) is trading at a price of 375.20, with a previous close of 384.00. The stock has fluctuated within a day range of 373.00 to 384.00, while its 52-week range spans from 318.40 to 748.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.